Medicine (의예과)3,519
-
1
Article
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)
김성배
;
Bhumsuk Keam
;
Hee Kyung Ahn
;
et al
2020
-
2
Article
Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors-proceedings from breast cancer expert group meeting
김성배
;
Cynthia Villarreal-Garza
;
Florencia Perazzo
;
et al
2020
-
3
Article
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study
김성배
;
Alice L Yu
;
Chiun-Sheng Huang
;
et al
2020
-
4
Article
A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy
고수진
;
김성배
;
김정은
;
et al
2020
-
5
Article
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
김성배
;
Aruna Mani
;
Chiara Lambertini
;
et al
2020
-
6
Article
Prognostic value of neutrophil-to-lymphocyte ratio in older patients with head and neck cancer
구자윤
;
김상윤
;
김성배
;
et al
2020
-
7
Article
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
김성배
;
Adam Knott
;
Andreas Schneeweiss
;
et al
2020
-
8
Article
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial
김성배
;
Andrew M Wardley
;
Arlene Chan
;
et al
2020
-
9
Article
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
김성배
;
Antoine Adenis
;
Chih-Hung Hsu
;
et al
2020
-
10
Article
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
김상위
;
Bong-Seog Kim
;
Byoung Chul Cho
;
et al
2020
-
11
Article
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis
김상위
;
Byoung Chul Cho
;
Cheol Hyeon Kim
;
et al
2020
-
12
Article
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study
김상위
;
Anders Mellemgaard
;
Byoung Chul Cho
;
et al
2020
-
13
Article
Prenatal PM 2.5 exposure and vitamin D-associated early persistent atopic dermatitis via placental methylation
양송이
;
이승화
;
이소연
;
et al
2020
-
14
Article
Quantile regression analysis of the socioeconomic inequalities in air pollution and birth weight
Dirga Kumar Lamichhane
;
이소연
;
안강모
;
et al
2020
-
15
Article
In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea
김성한
;
김태은
;
이승철
;
et al
2020
-
16
Article
TNF-α (rs1800629) polymorphism modifies the effect of sensitization to house dust mite on asthma and bronchial hyperresponsiveness in children
이은
;
이소연
;
박민지
;
et al
2020
-
17
Article
Impact of Environmental Factors on the Prevalence Changes of Allergic Diseases in Elementary School Students in Ulsan, Korea: A Longitudinal Study
이지호
;
윤석현
;
오인보
;
et al
2020
-
18
Article
Vegetable dietary pattern may protect mild and persistent allergic rhinitis phenotype depending on genetic risk in school children
오혜영
;
이소연
;
윤지선
;
et al
2020
-
19
Article
Sex-related impacts on clinical outcomes after percutaneous coronary intervention
박현우
;
한승봉
;
박경민
;
et al
2020
-
20
Article
Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management
김영학
;
김용균
;
노재형
;
et al
2020